Mumbai-based pharmaceutical giant Cipla will distribute and market the drug in India. Inhaled from the mouth at the beginning of a meal, Afrezza dissolves rapidly into the lungs and delivers ...

Drugmaker Cipla has got regulatory approval to market Afrezza, a rapid acting insulin delivered through an inhaler, as compared to other insulins given through injections. The Central Drugs ...